This news is covered by the Medical Dialogues Bureau present at the TCT Conference 2025, being held in San Francisco, USA.The STORM-PE randomized controlled trial, presented at TCT ...
The addition of sotatercept, an activin-signaling inhibitor, to background therapy results in a lower risk for clinical worsening among adults with pulmonary arterial hypertension who were diagnosed ...
Results from the first randomized controlled trial to directly compare the safety and efficacy of cutting balloon (CB) ...
The preferred timing of treatment of nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) ...
I am a 68-year-old woman who is in relatively good health. My primary exercise is walking my dogs anywhere from 2-5 miles per ...
News-Medical.Net on MSN
Cutting balloon angioplasty proves noninferior to intravascular lithotripsy in treating calcified coronary lesions
Results from the first randomized controlled trial to directly compare the safety and efficacy of cutting balloon (CB) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback